Repurposing an anti-cancer agent for the treatment of hypertrophic heart disease
{{output}}
Coronary microvascular dysfunction combined with maladaptive cardiomyocyte morphology and energetics is a major contributor to heart failure advancement. Thus, dually enhancing cardiac angiogenesis and targeting cardiomyocyte function to slow, or reverse, the ... ...